Most Recent Articles: BMC Urologyhttps://bmcurol.biomedcentral.comMost Recent Articles: BMC UrologyThe role of antimicrobial prophylaxis in laparoscopic nephrectomy for renal cell carcinomahttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01447-2To investigate the role of antimicrobial prophylaxis in laparoscopic nephrectomy for renal cell carcinoma.ResearchWed, 13 Mar 2024 00:00:00 GMThttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01447-2Mengchao Wei, Wenjie Yang, Weifeng Xu, Guanghua Liu, Yi Xie, Jie Dong and Zhigang Ji2024-03-13T00:00:00ZThe mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylationhttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01444-5Bladder cancer (BC) is one of the most common malignancies of the genitourinary system. Phosphofructokinase 1 (PFK-1) is one of member of PFK, which plays an important role in reprogramming cancer metabolism, ...ResearchWed, 13 Mar 2024 00:00:00 GMThttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01444-5Rong Wang, Fei Xu, Zhengjia Yang, Jian Cao, Liqi Hu and Yangyang She2024-03-13T00:00:00ZA contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinomahttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01423-wTo analyze surgical and oncologic outcomes of patients undergoing open partial nephrectomy (OPN) versus laparoscopic partial nephrectomy (LPN) for treatment of renal cell carcinoma (RCC).ResearchTue, 12 Mar 2024 00:00:00 GMThttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01423-wEdouard Nicaise, Adam S. Feldman, Andrew Gusev, Alice Yu, Naren Nimmagadda, Matthew F. Wszolek, Francis McGovern, Michael L. Blute and Douglas M. Dahl2024-03-12T00:00:00ZSurvival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysishttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01446-3B7-H3 has been implicated in clinical pathological features and prognosis across various cancer types, suggesting its potential as a cancer biomarker. Nevertheless, consensus remains elusive regarding its clin...ResearchMon, 11 Mar 2024 00:00:00 GMThttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01446-3Haohao sun, Fei Gao, Yuan Liu and Jianfeng Shao2024-03-11T00:00:00ZEfficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysishttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01438-3The effectiveness of immunosuppressive and corticosteroid treatments for Immunoglobulin A (IgA) nephropathy (IgAN) remains thoroughly evaluated. We undertook a meta-analysis to investigate the efficacy and saf...ResearchMon, 11 Mar 2024 00:00:00 GMThttps://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01438-3Dongxu Zhang, Bowen Xia, Xin Zhang, Pu Liang and Xiaopeng Hu2024-03-11T00:00:00Z